Changes in prescribing patterns and access to immune checkpoint inhibitors in german lung cancer patients – a claims data analysis

Abstract Background Recently, immune checkpoint inhibitors (ICIs) have driven profound changes in the treatment of non-small cell lung cancer (NSCLC). Their rapid integration into clinical routine is crucial for patient outcomes. However, prescribing patterns may not change immediately after authori...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Julia Walter, Blerina Resuli, Laura Sellmer, Diego Kauffmann-Guerrero, Toki Bolt, Chukwuka Eze, Jürgen Behr, Amanda Tufman
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2025-07-01
Edice:BMC Public Health
Témata:
NSCLC
Secondary data
Immunotherapy
Regional differences
Viral infections
Innovation.
On-line přístup:https://doi.org/10.1186/s12889-025-23846-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky